VICTORY CAPITAL MANAGEMENT INC

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1040188 San Antonio, TX

Position in KYMR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$8,524,567

+$2,861,264 QoQ

Shares Held

74,340

+9.3% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#80

of 273 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. KYMR ranks #28 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,524,567	74,340	+9.3%	Shares	Sole	2026-08-07
2026-03-31	$5,663,303	67,995	+1.4%	Shares	Sole	2026-05-15
2025-12-31	$5,219,961	67,086	+114.4%	Shares	Sole	2026-02-13
2025-09-30	$1,770,957	31,289	+5.6%	Shares	Sole	2025-11-12
2025-06-30	$1,293,184	29,633	+127.2%	Shares	Sole	2025-08-13
2025-03-31	$356,904	13,040	-34.5%	Shares	Sole	2025-05-02
2024-12-31	$800,536	19,899	+174.2%	Shares	Sole	2025-02-06
2024-09-30	$343,426	7,256	+2.9%	Shares	Sole	2024-11-05
2024-06-30	$210,472	7,051	-0.3%	Shares	Sole	2024-08-05
2024-03-31	$284,415	7,075	+26.2%	Shares	Sole	2024-05-03
2021-12-31	$355,988	5,607	-9.6%	Shares	Sole	2022-02-07
2021-09-30	$364,305	6,202	+19.8%	Shares	Sole	2021-11-02
2021-06-30	$251,181	5,179	—	Shares	Sole	2021-08-03
No filing history on record for this holder in this stock.